His research work has been at the forefront of understanding underlying genetic changes in cancer genomes through systematic identification of somatic mutations in large number of cancer types and subtypes using next generation sequencing and other novel techniques. Seshagiri and team have applied computational methods and functional assays to understand the role of cancer specific mutations in oncogenic signaling leading to new target discovery for therapeutic intervention.